rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Aurobindo Pharma Ltd.

524804 AUROPHARMA Group (A)

04 Oct,15:29
1464.30
6.50 (0.45%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Aurobindo Pharma Ltd.

BUYSELL

18,191 1,457.80 1,489.45 - 1,443.20 1,592.55 - 834.90 85,793.34
NSE | BSE

Aurobindo Pharma Ltd.

AUROPHARMA

04 Oct,15:53
1466.05
7.45 (0.51%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Aurobindo Pharma Ltd.

BUYSELL

923,928 1458.60 1,489.70 - 1,442.20 1,592.00 - 834.65 1,360,890,508.32

News for Aurobindo Pharma Ltd.

Aurobindo...
Aurobindo Subsidiary Gets USFDA Observations for API Plant
Aurobindo Pharma's subsidiary, Apitoria Pharma, received 10 observations from the USFDA after an inspection of its API facility in Telangana. The observations are procedural in nature and will be...
Sep 30, 2024 16:40
Aurobindo...
Aurobindo Acquires GLS Pharma for Rs 22.5 Crore
Aurobindo Pharma Ltd will acquire the remaining 49% stake in GLS Pharma Ltd for Rs 22.5 crore, making it a wholly-owned subsidiary. The deal is expected to be completed by December 31, 2024.
Sep 18, 2024 16:01
Aurobindo Pharma Gets First USFDA Approval for Generic Anaesthesia
Aurobindo Pharma's subsidiary, Eugia Steriles, has received its first product approval from the USFDA for Lidocaine Hydrochloride Injection, a generic anaesthesia medication.
Sep 11, 2024 17:58
Eugia Steriles' Injectable Facility Gets FDA Approval
Eugia Steriles's new injectables facility in Andhra Pradesh has received its first product approval from the US FDA, marking a significant milestone for the company.
Sep 11, 2024 14:23
Aurobindo,...
Aurobindo, Glenmark, FDC Recall Drugs in US: USFDA
Aurobindo, Glenmark, and FDC are recalling drugs in the US due to manufacturing issues, according to the USFDA. The recalls include pain relief medication, Indomethacin capsules, and Timolol...
Aug 26, 2024 19:01

More News for Aurobindo Pharma Ltd. »

(Rs. Crore)

Financial Results of Aurobindo Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales10,645.6412,792.2811,287.1415,823.6813,266.48
Operating profit2,224.041,730.921,473.404,119.822,685.75
Interest182.60114.9816.9428.6895.58
Gross profit2,657.502,049.702,127.454,681.002,848.18
EPS (Rs)33.3521.0024.8353.1331.96

See more in Research Center »

About Aurobindo Pharma Ltd.

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer. Wikipedia

News for Pharmaceuticals and health care

Stable Policies...
Stable Policies Boost India's Manufacturing Growth
Experts say stable policies and improved ease of doing business in Indian states will significantly boost the country's manufacturing sector, with renewable energy and electronics holding huge...
Oct 06, 2024 14:18
Eco Hotels...
Eco Hotels Targets Profitability by 2026, Expands Portfolio
Eco Hotels and Resorts aims to achieve profitability by March 2026. The company has acquired three properties, adding 178 rooms to its portfolio and plans to reach 5,000 rooms in the next five years.
Oct 06, 2024 14:16
SBI to Hire...
SBI to Hire 10,000 Employees in FY24: Focus on Tech &' General Banking
State Bank of India (SBI) plans to recruit 10,000 new employees in FY24, including tech specialists and general banking personnel. The bank is also expanding its branch network and focusing on...
Oct 06, 2024 14:07
Anil Ambani's...
Anil Ambani's Reliance Group Raises Rs 17,600 Crore for Growth
Reliance Infrastructure and Reliance Power secure Rs 17,600 crore funding through equity and debt instruments to fuel future expansion plans.
Oct 06, 2024 14:01
CII Business...
CII Business Confidence Index Hits 2-Quarter High, Industry Upbeat on Policy Continuity
The CII Business Confidence Index rose to 68.2 for July-September, driven by policy continuity and strong economic momentum. The index reflects optimism in the industry despite global challenges.
Oct 06, 2024 13:42

More News »

Top News

Stable Policies...
Stable Policies Boost India's Manufacturing Growth
Experts say stable policies and improved ease of doing business in Indian states will significantly boost the country's manufacturing sector, with renewable energy and electronics holding huge...
Oct 06, 2024 14:18
Eco Hotels...
Eco Hotels Targets Profitability by 2026, Expands Portfolio
Eco Hotels and Resorts aims to achieve profitability by March 2026. The company has acquired three properties, adding 178 rooms to its portfolio and plans to reach 5,000 rooms in the next five years.
Oct 06, 2024 14:16
SBI to Hire...
SBI to Hire 10,000 Employees in FY24: Focus on Tech &' General Banking
State Bank of India (SBI) plans to recruit 10,000 new employees in FY24, including tech specialists and general banking personnel. The bank is also expanding its branch network and focusing on...
Oct 06, 2024 14:07
Anil Ambani's...
Anil Ambani's Reliance Group Raises Rs 17,600 Crore for Growth
Reliance Infrastructure and Reliance Power secure Rs 17,600 crore funding through equity and debt instruments to fuel future expansion plans.
Oct 06, 2024 14:01
CII Business...
CII Business Confidence Index Hits 2-Quarter High, Industry Upbeat on Policy Continuity
The CII Business Confidence Index rose to 68.2 for July-September, driven by policy continuity and strong economic momentum. The index reflects optimism in the industry despite global challenges.
Oct 06, 2024 13:42

More Top News »

Report Card

PE Ratios
43.90
EPS (Rs.)
33.35
Sales (Rs. Cr)
2,460.09
Face Value (Rs.)
1
Net Profit Margin (%)
18.35
Last Bonus
1:1
Last Dividend(%)
150
Return on Average Equity
9.9

Compare 'Aurobindo Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,913.60
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,734.70
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,068.85
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,902.80
  • Compare
  • Max Healthcare Institute Ltd.
  • 941.05
  • Compare
  • Alkem Laboratories Ltd.
  • 6,159.25
  • Compare
  • Divi's Laboratories Ltd.
  • 5,428.70
  • Compare

Most Active

  • Change (Rs.)
  •  

Aurobindo Pharma Ltd. performance snapshot

If you had invested Rs.  in Aurobindo Pharma Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close